Pin Wang

University of Southern California — United States

Medicine · Health Sciences

48h-index7.8kcitations213works8.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

CAR-T cell therapy research(86), Virus-based gene therapy research(43), Immunotherapy and Immune Responses(41), RNA Interference and Gene Delivery(39), Immune Cell Function and Interaction(34)

Publications212 total

Precision In Vivo CAR-T generation via CLAMP-enabled mRNA delivery: Toward scalable and translatable cell therapy
Blood·2025· 1 citedOpen Access
385 A bispecific engager-secreting TIL therapy designed to penetrate stromal barriers and boost tumor killing in solid tumors
Regular and Young Investigator Award Abstracts·2025Open Access
290 A translatable in vivo CAR-T platform enabled by CLAMP technology for targeted mRNA delivery to T cells
Regular and Young Investigator Award Abstracts·2025Open Access
High-fidelity AaCas12bMax enables the development of an engineered T cell therapy with enhanced safety and functional fitness
Molecular Therapy·2025Open Access
Overcoming ovarian cancer resistance and evasion to CAR-T cell therapy by harnessing allogeneic CAR-NKT cells
Med·2025· 15 citedOpen Access
Role of APE1 redox function in chronic rhinosinusitis pathogenesis: Implications for targeted therapy
Journal of Allergy and Clinical Immunology·2025· 1 cited
Evaluating the safety and efficacy of CRISPR/AaCas12b <sup>Max</sup> -modified tumor infiltrating lymphocytes (GT300) as monotherapy in advanced solid tumors.
Journal of Clinical Oncology·2025· 1 cited
Abstract 865: Engineering a next-generation dual-knockout TIL product with AaCas12b nuclease editing
Cancer Research·2025
Abstract 3192: GT316: a next-generation TIL therapy identified through genome-wide CRISPR screening with promising efficacy in advanced solid tumors
Cancer Research·2025
Abstract 866: Next-generation neoantigen vaccines powered by AI-assisted discovery and APC-targeted delivery platforms
Cancer Research·2025
Allogeneic CD33-directed CAR-NKT cells for the treatment of bone marrow-resident myeloid malignancies
Nature Communications·2025· 33 citedOpen Access
Integrating lanthanide coordination polymer ratiometric fluorescence biosensors with a concatenated DNA circuit for locus-specific <i>N</i><sup>6</sup>-methyladenosine quantification
Chemical Communications·2025
Mussel-inspired adhesive drug-loaded hydrogels for oral ulcers treatment
Acta Biomaterialia·2024· 30 cited
Genetic polymorphisms of <i>LMX1B</i> and <i>MLXIP</i> are associated with hip osteoarthritis in the Chinese population
Biomarkers in Medicine·2024· 1 citedOpen Access
A first-in-human study of CRISPR/Cas9-engineered tumor infiltrating lymphocytes (TILs) product GT316 as monotherapy in advanced solid tumors.
Journal of Clinical Oncology·2024· 2 cited
Phase 1 study of GT101 as an autologous tumor infiltrating lymphocyte (TIL) therapy in advanced solid tumors.
Journal of Clinical Oncology·2024
Generation of allogeneic CAR-NKT cells from hematopoietic stem and progenitor cells using a clinically guided culture method
Nature Biotechnology·2024· 67 citedOpen Access
Transdifferentiation of epithelial cells and fibroblasts induced by IL-1β fuels neutrophil recruitment in chronic rhinosinusitis
2024· 1 citedOpen Access
Effect of the staging comprehensive treatment with acupuncture-moxibustion on Bell's facial palsy in the acute stage.
PubMed·2024· 4 cited
Potential window alignment regulating ion transfer in faradaic junctions for efficient photoelectrocatalysis
Nature Communications·2023· 11 citedOpen Access
page 1 of 11Next →

Frequent Co-authors

Yarong Liu(13), Kye‐Il Joo(10), Lili Yang(9), Kwang Gi Kim(7), Biliang Hu(7), Yi Tang(7), Elizabeth L. Siegler(7), Zhen Gu(6), Li Lin(5), Natnaree Siriwon(5), Jinxu Fang(5), Jennifer A. Rohrs(5), Zachary Spencer Dunn(5), Xuetao Cao(4), Si Li(4), Xiaoyang Zhang(4), John Mac(4), Xiaolu Han(4), David Baltimore(4), Muxun Zhao(4)